CEBPB and cancer: Our findings show that pre-treatment with Dpep, a cell-penetrating peptide designed to target the transcription factors ATF5, CEBPB, and CEBPD, sensitizes a variety of cultured cancer cells to the cytotoxic activity of NK-92MI cells.